BATON ROUGE – Critics throughout the country question why Dsuvia drugs are needed. These are recent opioids and painkillers that were stamped with FDA approval, but many disagree and consider them a big mistake.
"We are in the midst of the worst possible epidemic that is an opioid epidemic in this country that might kill and injure more people than any other epidemic than the country, or the world has seen," Coroner Beau Clark said.
East Baton Rouge Parish Coroner, Dr. Bee Clark has seen firsthand the fatal effects of Opioid use with at least 72 overdose deaths in the parish this year.
"This seems to completely ignore human life. We talk about a substance, Opioids that kill people, why we need more when we have a problem with what we have, "Clark said.
According to the FDA, there are strict guidelines for drugs that dissolve in your mouth. It can only be used in hospitals, surgical centers, and emergency rooms. Dsuvia cannot be used more than 72 hours, and is not available at retail pharmacies.
They say this is a drug that will only be given in health care facilities for a very short time in a very controlled environment. That's good if that's the problem. However, later in the statement, they said this was also developed with the Department of Defense, so that it also contradicted itself.
In a statement from the FDA commission, Dr. Scott Gottlieb said, "This Opioid formulation, together with the unique Dsuvia delivery device is a medial priority product for the Pentagon because it fulfills specific and vital but limited needs that are not met in treating our nation's army on the battlefield, but Dr. Clark did not buy it.
"A soldier out there protects our country, and if they are injured on the battlefield we must have a mechanism to manage their pain especially if they have a long transportation time from where they get injured and definitely care but I think those things already exists, "Clark said.
Serious risks of using Dsuvia include respiratory depression, coma, and even death and not to mention very addictive qualities.
"Having strong and strong Opioids is really the wrong direction and of course sending the wrong message." In Dr.'s statement Gottlieb about Dsuvia, he added: "We will not rule out what I believe is a source of real dissatisfaction among critics. It agrees with the question of whether America needs other strong opioids in the throes of a major addiction crisis."
Gottlieb said that the question would be handled openly and directly. Dsuvia is set to bring 1.1 billion dollars in annual sales, but for Clark, he cares more about life that can be lost in the future.
"We are on track for another record year by increasing the number of Opioids compared to last year, and I don't see the end seen, and when we do something like this, and we make another category that is stronger Opioid. I think it leads to more problem, "Clark said.
For more information about Dsuvia, click here.